中文名称:灰毒素III半(乙酸乙酯)*加合物
- 灰毒素III; 仙雄腈; BRN 2059374; 脱乙酰腺毒素; (3-β,6-β,14R)-灰氧毒素-3,5,6,10,14,16-己醇; NSC 323778; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-己醇; (2S,3as,4R,4ar,7R,8R,9as,11R,11a,12R)-十二氢-1,1,4,8-环戊烯-2,4,8,11,11a,12(1H)-己醇-7,9a-甲桥-9aH-环戊二烯(b)庚烯-2,4,8,11,11,11a-12R)-; (3beta,6beta,14R)-(9CI)-3,5,6,10,14,16-己醇; 灰氧烷-3,5,6,10,14,16-己醇; (1β,3α,5α,6α,8β,9α,10α,13β,14S)-灰氧烷-3,5,6,10,14,16-己醇; (3beta,6beta)-灰氧烷-3,5,6,10,14,16-己醇
- grayanotoxin iii hemi(ethyl acetate)*adduct
- Grayanotoxin III; Andromedol; BRN 2059374; Deacetylandromedotoxin; Deacylasebotoxin I; Grayanotoxane-3,5,6,10,14,16-hexol, (3-beta,6-beta,14R)-; NSC 323778; (3beta,6beta,14R)-Grayanotoxane-3,5,6,10,14,16-hexol; 7,9a-Methano-9aH-cyclopenta(b)heptalene-2,4,8,11,11a,12(1H)-hexol, dodecahydro-1,1,4,8-tetramethyl-, (2S,3as,4R,4ar,7R,8R,9as,11R,11aR,12R)-; Grayanotoxane-3,5,6,10,14,16-hexol, (3beta,6beta,14R)- (9CI); grayanotoxane-3,5,6,10,14,16-hexol; (1beta,3alpha,5alpha,6alpha,8beta,9alpha,10alpha,13beta,14S)-grayanotoxane-3,5,6,10,14,16-hexol; (3beta,6beta)-grayanotoxane-3,5,6,10,14,16-hexol
- 4678-45-9
- C20H34O6
- 370.4804
- InChI=1/C20H34O6/c1-16(2)13(21)7-12-18(4,25)11-6-5-10-15(23)19(11,9-17(10,3)24)8-14(22)20(12,16)26/h10-15,21-26H,5-9H2,1-4H3/t10?,11-,12-,13-,14+,15?,17+,18+,19-,20-/m0/s1
- 1.36g/cm3
- 552.6°C at 760 mmHg
- 250.9°C
- 1.63E-14mmHg at 25°C
化工网